Compare DexCom, Inc. (DXCM) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Warner Music Group Corp — how do they compare? DexCom, Inc. trades at $77.08 (market cap $28.06B), while Warner Music Group Corp trades at $28.53 (market cap $14.77B). The key difference: DexCom, Inc. is the larger of the two by market cap, and Warner Music Group Corp pays a 2.68% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WMG | |
|---|---|---|
Market Cap | $28.06B | $14.77B |
Sector | Health | Media |
52-Week High | $89.53 | $34.72 |
52-Week Low | $54.84 | $23.65 |
Enterprise Value | $27.03B | $18.97B |
Dividend Yield | — | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Warner Music Group (WMG) trades at $28.45, up 3.19% today, with a bearish technical signal despite recent earnings beats. The company shows steady revenue growth to $6.71B in 2025, though net margins have compressed to 5.44%. Recent acquisitions like Sureel AI (June 10, 2026) aim to strengthen IP monetization in the AI era, while analyst consensus remains bullish with a $40.40 price target.
WMG offers upside potential from streaming growth and AI initiatives, but faces risks from margin pressure and competitive content spending. The stock's high P/E of 33.71 suggests elevated expectations, requiring execution on profit improvement to justify valuation. Near-term support lies at $28, with resistance at $29.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
